Gene panel testing of 5589 BRCA1/2 -negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gene panel testing of 5589 BRCA1/2
-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer
Authors
Keywords
-
Journal
Cancer Medicine
Volume 7, Issue 4, Pages 1349-1358
Publisher
Wiley
Online
2018-03-09
DOI
10.1002/cam4.1376
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls
- (2017) Jenna Lilyquist et al. GYNECOLOGIC ONCOLOGY
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
- (2017) Fergus J. Couch et al. JAMA Oncology
- Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer
- (2017) Eric Hahnen et al. JAMA Oncology
- Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care
- (2016) Ella R. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence ofBRCA1/2germline mutations in 21 401 families with breast and ovarian cancer
- (2016) Karin Kast et al. JOURNAL OF MEDICAL GENETICS
- Analysis of protein-coding genetic variation in 60,706 humans
- (2016) Monkol Lek et al. NATURE
- Inherited Mutations in Women With Ovarian Carcinoma
- (2016) Barbara M. Norquist et al. JAMA Oncology
- Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
- (2015) Gaëlle Bougeard et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families
- (2015) Jun Li et al. JOURNAL OF MEDICAL GENETICS
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
- (2015) Douglas F. Easton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protein-truncating variants in moderate-risk breast cancer susceptibility genes: A meta-analysis of high-risk case-control screening studies
- (2015) Fatima Aloraifi et al. Cancer Genetics
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- An Evaluation of Copy Number Variation Detection Tools from Whole-Exome Sequencing Data
- (2014) Renjie Tan et al. HUMAN MUTATION
- Breast-Cancer Risk in Families with Mutations in PALB2
- (2014) Antonis C. Antoniou et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Effect of CHEK2 Variant I157T on Cancer Susceptibility: Evidence from a Meta-Analysis
- (2013) Fei-fei Han et al. DNA AND CELL BIOLOGY
- Significant association between Nijmegen breakage syndrome 1 657del5 polymorphism and breast cancer risk
- (2013) Guofeng Zhang et al. TUMOR BIOLOGY
- CHEK2*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer–Specific Death, and Increased Risk of a Second Breast Cancer
- (2012) Maren Weischer et al. JOURNAL OF CLINICAL ONCOLOGY
- A Finnish founder mutation inRAD51D: analysis in breast, ovarian, prostate, and colorectal cancer: Table 1
- (2012) Liisa M Pelttari et al. JOURNAL OF MEDICAL GENETICS
- Germline RAD51C mutations confer susceptibility to ovarian cancer
- (2012) Chey Loveday et al. NATURE GENETICS
- RAD51C is a susceptibility gene for ovarian cancer
- (2011) Liisa M. Pelttari et al. HUMAN MOLECULAR GENETICS
- Germline mutations in RAD51D confer susceptibility to ovarian cancer
- (2011) Chey Loveday et al. NATURE GENETICS
- Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
- (2010) Alfons Meindl et al. NATURE GENETICS
- The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype
- (2009) T. Heikkinen et al. CLINICAL CANCER RESEARCH
- Penetrance Analysis of the PALB2 c.1592delT Founder Mutation
- (2008) H. Erkko et al. CLINICAL CANCER RESEARCH
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results
- (2008) Sharon E. Plon et al. HUMAN MUTATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started